Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C
暂无分享,去创建一个
J. Kench | K. Byth | O. Lux | J. George | G. Farrell | G. McCaughan | D. Naidoo | C. Salonikas | Priyanka Bandara
[1] H. Jaeschke,et al. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. , 2003, Toxicology letters.
[2] M. Evans,et al. Oxidative DNA damage: mechanisms, mutation, and disease , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[3] P. Pemberton,et al. Oxidant stress is a significant feature of primary biliary cirrhosis. , 2003, Biochimica et biophysica acta.
[4] J. George,et al. Interaction of iron, insulin resistance, and nonalcoholic steatohepatitis , 2003, Current gastroenterology reports.
[5] T. Asselah,et al. Fibrosis and disease progression in hepatitis C , 2002 .
[6] T. Asselah,et al. Fibrosis and disease progression in hepatitis C , 2002, Hepatology.
[7] F. Wrba,et al. Hepatocellular fat accumulation and low serum cholesterol in patients infected with HCV-3a , 2002, American Journal of Gastroenterology.
[8] C. Lieber. S-adenosyl-L-methionine: its role in the treatment of liver disorders. , 2002, The American journal of clinical nutrition.
[9] J. Hoofnagle,et al. Use of complementary and alternative medicine in patients with liver disease , 2002, American Journal of Gastroenterology.
[10] P. Pemberton,et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. , 2002, Journal of hepatology.
[11] M. Cappellini,et al. Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis , 2002, European journal of clinical investigation.
[12] J. Kaldor,et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection , 2001, Hepatology.
[13] J. Hoofnagle,et al. Complementary and alternative medicine in chronic liver disease , 2001, Hepatology.
[14] G. Robino,et al. Oxidative stress-related molecules and liver fibrosis. , 2001, Journal of hepatology.
[15] Z. Goodman,et al. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c. , 2001, Journal of hepatology.
[16] G. Cioni,et al. Antioxidant liposoluble vitamins and carotenoids in chronic hepatitis. , 2001, European journal of internal medicine.
[17] S. I. Lee,et al. Oxidative stress effect on the activation of hepatic stellate cells. , 2001, Yonsei medical journal.
[18] P. Portincasa,et al. Oxidative stress in symptom‐free HCV carriers: relation with ALT flare‐up , 2001, European journal of clinical investigation.
[19] G. Marchesini,et al. Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis. , 2000, Metabolism: clinical and experimental.
[20] M. Zaretsky,et al. N‐acetylcysteine replenishes glutathione in HIV infection , 2000, European journal of clinical investigation.
[21] E. Mosharov,et al. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. , 2000, Biochemistry.
[22] D. Purdie,et al. Host genetic factors influence disease progression in chronic hepatitis C , 2000, Hepatology.
[23] S. French,et al. Mechanisms of alcoholic liver injury. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[24] O. Griffith,et al. Biologic and pharmacologic regulation of mammalian glutathione synthesis. , 1999, Free radical biology & medicine.
[25] H. Sies,et al. Glutathione and its role in cellular functions. , 1999, Free radical biology & medicine.
[26] G. Filice,et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings , 1999, American Journal of Gastroenterology.
[27] R. Brigelius-Flohé,et al. Vitamin E: function and metabolism , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] G. Barbarini,et al. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. , 1999, Journal of hepatology.
[29] T. Yoshikawa,et al. Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. , 1998, Biochemical and biophysical research communications.
[30] J. Kench,et al. How much does alcohol contribute to the variability of hepatic fibrosis in chronic hepatitis C? , 1998, Journal of gastroenterology and hepatology.
[31] F. Ridolfi,et al. Fibrogenic effect of oxidative stress on rat hepatic stellate cells , 1998, Hepatology.
[32] V. Paradis,et al. In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features. , 1997, Journal of clinical pathology.
[33] J. Juszczyk,et al. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis , 1997, Journal of viral hepatitis.
[34] C. Niederau,et al. Diminished plasma levels of vitamin E in patients with severe viral hepatitis. , 1996, Free radical research.
[35] G. Barbarini,et al. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease. , 1996, The American journal of gastroenterology.
[36] B. Mills,et al. Differential distribution of free and bound glutathione and cyst(e)ine in human blood. , 1996, Biochemical pharmacology.
[37] C. Del Vecchio Blanco,et al. Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis. , 1996, Scandinavian journal of clinical and laboratory investigation.
[38] M. Zoli,et al. Defective methionine metabolism in cirrhosis: Relation to severity of liver disease , 1992, Hepatology.
[39] P. Scheuer,et al. Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.
[40] T. Toyo’oka,et al. High-performance liquid chromatography and fluorometric detection of biologically important thiols, derivatized with ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulphonate (SBD-F). , 1983, Journal of chromatography.
[41] V. Raisys,et al. Ascorbic acid in lymphocytes: cell preparation and liquid-chromatographic assay. , 1982, Clinical chemistry.
[42] J. Henderson,et al. Evidence for impairment of transsulfuration pathway in cirrhosis , 1981 .
[43] M. Anderson,et al. Dynamic state of glutathione in blood plasma. , 1980, The Journal of biological chemistry.
[44] J P de la Cruz,et al. Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis. Results of a randomized, double-blind, placebo-controlled clinical study. , 2002, International journal of clinical pharmacology and therapeutics.
[45] R. Mulcahy,et al. The enzymes of glutathione synthesis: gamma-glutamylcysteine synthetase. , 1999, Advances in enzymology and related areas of molecular biology.
[46] N. Kaplowitz,et al. Role of the Liver in Interorgan Homeostasis of Glutathione and Cyst(e)ine , 1998, Seminars in liver disease.
[47] C. Lieber. Role of oxidative stress and antioxidant therapy in alcoholic and nonalcoholic liver diseases. , 1997, Advances in pharmacology.
[48] D. V. van Thiel,et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. , 1996, Free radical biology & medicine.
[49] S. Heymsfield,et al. Evidence for impairment of transsulfuration pathway in cirrhosis. , 1981, Gastroenterology.
[50] L. Holmberg,et al. Determination of plasma α-tocopherol by high-performance liquid chromatography , 1978 .
[51] L. Holmberg,et al. Determination of plasma alpha-tocopherol by high-performance liquid chromatography. , 1978, Journal of Chromatography A.